î
îŒ
ãã°ã€ã³
î
Quanterix Corp
QTRX3.425USD
-0.475-12.18%
çµå€Â 03/30, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
69.34Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Quanterix Corp äŒæ¥å
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Companyâs Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Quanterix Corpã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãQTRX
äŒç€ŸåQuanterix Corp
äžå Žæ¥Dec 07, 2017
æé«çµå¶è²¬ä»»è
ãCEOãToloue (Masoud)
åŸæ¥å¡æ°471
蚌åžçš®é¡Ordinary Share
決ç®ææ«Dec 07
æ¬ç€Ÿæåšå°900 Middlesex Turnpike
éœåžBILLERICA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·01821
é»è©±çªå·16173019400
ãŠã§ããµã€ãhttps://www.quanterix.com/
äŒæ¥ã³ãŒãQTRX
äžå Žæ¥Dec 07, 2017
æé«çµå¶è²¬ä»»è
ãCEOãToloue (Masoud)
Quanterix Corpã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
282.30K
-0.64%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
140.51K
+1.69%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
49.78K
+46.95%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
31.59K
+80.14%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
30.34K
+83.44%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
27.33K
+85.53%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
11.64K
+10.21%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
282.30K
-0.64%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
140.51K
+1.69%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
49.78K
+46.95%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
31.59K
+80.14%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
30.34K
+83.44%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
27.33K
+85.53%
åçå èš³
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Product revenue
26.15M
0.00%
Service and other revenue
13.95M
0.00%
Collaboration and license revenue
46.00K
0.00%
å°åå¥USD
äŒç€Ÿå
åç
æ¯ç
North America
24.39M
0.00%
EMEA
11.08M
0.00%
Asia Pacific
4.68M
0.00%
äºæ¥å¥
å°åå¥
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Product revenue
26.15M
0.00%
Service and other revenue
13.95M
0.00%
Collaboration and license revenue
46.00K
0.00%
æ ªäž»
æŽæ°æå»: Sat, Feb 21
æŽæ°æå»: Sat, Feb 21
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Portolan Capital Management, L.L.C.
9.64%
Columbia Threadneedle Investments (UK)
6.65%
BlackRock Institutional Trust Company, N.A.
6.57%
The Vanguard Group, Inc.
5.70%
Telegraph Hill Partners
5.34%
ä»ã®
66.10%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Portolan Capital Management, L.L.C.
9.64%
Columbia Threadneedle Investments (UK)
6.65%
BlackRock Institutional Trust Company, N.A.
6.57%
The Vanguard Group, Inc.
5.70%
Telegraph Hill Partners
5.34%
ä»ã®
66.10%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Investment Advisor/Hedge Fund
41.94%
Investment Advisor
21.55%
Hedge Fund
10.99%
Individual Investor
6.32%
Private Equity
5.34%
Research Firm
3.38%
Pension Fund
0.33%
Venture Capital
0.16%
Bank and Trust
0.15%
ä»ã®
9.85%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Thu, Jan 1
æŽæ°æå»: Thu, Jan 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
383
38.38M
82.16%
-7.31M
2025Q3
384
34.11M
73.41%
-9.53M
2025Q2
391
36.46M
81.18%
-12.95M
2025Q1
401
40.45M
104.19%
-6.42M
2024Q4
388
38.02M
98.63%
-6.28M
2024Q3
386
36.47M
95.03%
-5.94M
2024Q2
394
35.66M
93.20%
-9.57M
2024Q1
395
35.56M
93.43%
-9.17M
2023Q4
388
34.77M
91.99%
-10.35M
2023Q3
382
36.53M
97.35%
-9.84M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Portolan Capital Management, L.L.C.
4.26M
9.12%
+626.23K
+17.23%
Sep 30, 2025
Columbia Threadneedle Investments (UK)
3.14M
6.71%
+8.77K
+0.28%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.86M
6.12%
+212.22K
+8.01%
Sep 30, 2025
The Vanguard Group, Inc.
2.65M
5.67%
+118.56K
+4.69%
Sep 30, 2025
Telegraph Hill Partners
2.50M
5.36%
+2.50M
--
Sep 30, 2025
Blue Water Life Science Advisors, LP.
957.75K
2.05%
--
--
Sep 30, 2025
William Blair Investment Management, LLC
1.32M
2.82%
+187.30K
+16.60%
Sep 30, 2025
Walt (David R)
1.86M
3.99%
+2.59K
+0.14%
Oct 01, 2025
Columbia Threadneedle Investments (US)
1.11M
2.37%
-2.14K
-0.19%
Sep 30, 2025
Invenomic Capital Management LP
1.39M
2.98%
+248.10K
+21.67%
Sep 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Tue, Dec 2
æŽæ°æå»: Tue, Dec 2
éæå
æ¯ç
Invesco NASDAQ Future Gen 200 ETF
0.63%
iShares Micro-Cap ETF
0.04%
Fidelity Enhanced Small Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.03%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Biotechnology ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Value ETF
0.01%
Global X Russell 2000 ETF
0.01%
詳现ãèŠã
Invesco NASDAQ Future Gen 200 ETF
æ¯ç0.63%
iShares Micro-Cap ETF
æ¯ç0.04%
Fidelity Enhanced Small Cap ETF
æ¯ç0.03%
Avantis US Small Cap Equity ETF
æ¯ç0.03%
Invesco RAFI US 1500 Small-Mid ETF
æ¯ç0.02%
iShares Biotechnology ETF
æ¯ç0.02%
Proshares Ultra Russell 2000
æ¯ç0.01%
ProShares UltraPro Russell2000
æ¯ç0.01%
iShares Russell 2000 Value ETF
æ¯ç0.01%
Global X Russell 2000 ETF
æ¯ç0.01%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
